Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Inventory (2016 - 2025)

Historic Inventory for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $18.8 million.

  • Niagen Bioscience's Inventory rose 7821.51% to $18.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 7821.51%. This contributed to the annual value of $9.2 million for FY2024, which is 3671.6% down from last year.
  • Latest data reveals that Niagen Bioscience reported Inventory of $18.8 million as of Q3 2025, which was up 7821.51% from $14.4 million recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Inventory registered a high of $18.8 million during Q3 2025, and its lowest value of $9.2 million during Q4 2024.
  • Its 5-year average for Inventory is $13.3 million, with a median of $12.6 million in 2021.
  • As far as peak fluctuations go, Niagen Bioscience's Inventory crashed by 3671.6% in 2024, and later surged by 7821.51% in 2025.
  • Over the past 5 years, Niagen Bioscience's Inventory (Quarter) stood at $13.6 million in 2021, then increased by 7.91% to $14.7 million in 2022, then fell by 1.04% to $14.5 million in 2023, then tumbled by 36.72% to $9.2 million in 2024, then skyrocketed by 104.43% to $18.8 million in 2025.
  • Its Inventory was $18.8 million in Q3 2025, compared to $14.4 million in Q2 2025 and $11.2 million in Q1 2025.